a San Diego, CA based contract research organization (CRO), to file its investigational new drug (IND), and identify and supervise the next phase of clinical development trial sites for the use of RP-323 in Acute Myelocytic Leukemia
Coverage of the Acute Myelocytic Leukemia
pipeline on the basis of therapeutic class, route of administration and molecule type.
This report provides comprehensive information on the therapeutic development for Acute Myelocytic Leukemia
(AML, Acute Myeloblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Table 4: Acute Myelocytic Leukemia
, Global, Primary and Secondary Endpoints of Phase II Molecules, 2010 25
According to VanEenwyk, "The cancer statistics tell us that, although there may have been elevated risk of glioblastoma in the past, it appears people who live around the airport are not currently at a higher risk for glioblastoma, acute myelocytic leukemia
or breast cancer.
According to the American Cancer Society, acute myeloid leukemia (AML), also known as acute myelocytic leukemia
or acute myelogenous leukemia, is a cancer that begins in cells that normally develop into blood cells.
The trial is an open-label, multi-center, dose-escalation study designed to examine the safety, tolerability and pharmacokinetics of SNS-595 in order to establish an optimal dosing regimen for use in planned Phase II clinical testing of patients with relapsed or refractory acute myelocytic leukemia
(AML) and potentially other acute leukemias.
2001, Alice Masticola of Louisville, KY, suffered severe leg pain that was diagnosed as Acute Myelocytic Leukemia
LaMonica Molette, a 21-year-old Detroit resident, was diagnosed in December 2001 with acute myelocytic leukemia
Food and Drug Administration (FDA) for its Investigational New Drug (IND) to conduct clinical trials for its lead compound RP-323 in Acute Myelocytic Leukemia
(AML) and Myelodysplastic Syndrome (MDS).